Abbas Fotovati

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts.

Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts.

Journal: Gut microbes

Published: December 01, 2020

Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists.

Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists.

Journal: Cancers

Published: December 19, 2019

TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.

TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.

Journal: Cellular microbiology

Published: October 14, 2018

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.

Journal: Molecular cancer research : MCR

Published: August 01, 2017

HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development.

HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development.

Journal: eLife

Published: May 16, 2017

EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.

EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.

Journal: Cancer

Published: August 21, 2014

Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Journal: Cancer research

Published: September 11, 2013

YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.

YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.

Journal: Stem cells (Dayton, Ohio)

Published: April 05, 2013

Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.

Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.

Journal: Oncotarget

Published: October 11, 2012

Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.

Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.

Journal: Stem cells (Dayton, Ohio)

Published: June 08, 2012

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

Journal: Stem cells (Dayton, Ohio)

Published: March 15, 2012

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.

Journal: Oncogene

Published: January 18, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026